Cell Signaling Technology

PathScan® Phospho-Chk2 (Thr68) Sandwich ELISA Kit

#7037 · $661

100
Citing papers
8.3k
Combined citations
Supplier page Find this product

Research areas

PI3K/AKT/mTOR signaling in cancer14Myeloproliferative Neoplasms: Diagnosis and Treatment11Melanoma and MAPK Pathways9Cancer-related Molecular Pathways7Cancer, Hypoxia, and Metabolism6Metabolism, Diabetes, and Cancer6Cytokine Signaling Pathways and Interactions5Lymphoma Diagnosis and Treatment5

Papers citing this product

1
Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases
The EMBO Journal·2004·461 cit.·DOI
2
Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)
International Journal of Oncology·2015·363 cit.·DOI
3
DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells
Cell Death and Differentiation·2006·356 cit.·DOI
4
Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2
Journal of Clinical Investigation·2007·332 cit.·DOI
5
Systemic Inflammation Alters the Kinetics of Cerebrovascular Tight Junction Disruption after Experimental Stroke in Mice
Journal of Neuroscience·2008·311 cit.·DOI
6
Galectin-3 Is Required for Resident Microglia Activation and Proliferation in Response to Ischemic Injury
Journal of Neuroscience·2012·249 cit.·DOI
7
Interleukin-33 Is Biologically Active Independently of Caspase-1 Cleavage
Journal of Biological Chemistry·2009·245 cit.·DOI
8
Effects of Hydrogen Peroxide on Wound Healing in Mice in Relation to Oxidative Damage
PLoS ONE·2012·209 cit.·DOI
9
Estrogen Stimulates Postsynaptic Density-95 Rapid Protein Synthesis via the Akt/Protein Kinase B Pathway
Journal of Neuroscience·2003·196 cit.·DOI
10
Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients
Blood·2015·184 cit.·DOI
PathScan® Phospho-Chk2 (Thr68) Sandwich ELISA Kit — Evidence — PubIndex